NCT07059936招募中不适用
Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)
Wuhan Union Hospital, China1 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2025年7月1日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 350
- 试验地点
- 1
- 主要终点
- disease-free survival
研究概览
简要总结
CT imaging data and MR imaging data from liver cancer (hepatocellular carcinoma) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients were treated for hepatocellular carcinoma in Wuhan Union Hospital from July 2025 to July 2026;
- •Aged > 18 years old;
- •At least one CT scan or MR scan before treatment;
- •Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.
- •Exclusion criteria:
- •Poor image quality;
- •Incomplete clinical data or loss of follow-up;
- •Presence of another primary malignancy other than liver cancer;
- •Unclear pathological diagnosis.
排除标准
- 未提供
结局指标
主要结局
disease-free survival
时间窗: 1 year
Progression-free survival
时间窗: 1 year
overall survival
时间窗: 1 year
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal CancerColorectal CancerNCT01292681Radboud University Medical Center60
已完成
1 期
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)Primary Liver CancerNCT01116804University Hospital, Ghent36
已完成
4 期
Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) TherapyLiver CancerNCT04707547Taipei Medical University WanFang Hospital5
撤回
不适用
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver CancerPrimary Liver CancerCombined Hepatocellular-cholangiocarcinomaHepatocellular CarcinomaIntrahepatic CholangiocarcinomaNCT05292443Geneplus-Beijing Co. Ltd.
Unknown
2 期
Study of Immune Response and Liver Damage Induced by Chemotherapy for Liver Metastases of Colorectal CancerResectable Hepatic Metastases of Colorectal CancerNCT01673607Poitiers University Hospital30